However, it is hyperinsulinaemia, as a result of insulin resistance in classical metabolic tissues, which has been identified as a highly significant risk factor to progression of prostate and other cancers [ 14 ].
← all excerpts
New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication.
2
—
—
The sentences
Major findings from recent studies [ 36 , 143 ] and our own recent pilot study of men receiving ADT demonstrated a strong trend between elevated C-peptide and more rapid progression to CRPC.